Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Advagene Biopharma Co., Ltd. (6709) Income Statement

Advagene Biopharma Co., Ltd. Income Statement

Last quarter (Q2 2026), Advagene Biopharma Co., Ltd.'s total revenue was NT$0.00. In Q2, Advagene Biopharma Co., Ltd.'s net income was NT$-55.84M. See Advagene Biopharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00
NT$ -2.19MNT$ -2.18MNT$ -12.00MNT$ -11.60MNT$ -7.72M
NT$ 68.73MNT$ 68.64MNT$ 93.34MNT$ 119.81MNT$ 94.43M
Depreciation and AmortizationNT$ 2.19MNT$ 2.18MNT$ 12.00MNT$ 11.60MNT$ 7.72M
NT$ -68.73MNT$ -67.09MNT$ -80.07MNT$ -106.69MNT$ -84.83M
NT$ -70.92MNT$ -70.82MNT$ -93.34MNT$ -119.81MNT$ -94.43M
NT$ 2.63MNT$ 1.40MNT$ 1.23MNT$ 1.43MNT$ 1.74M
NT$ -68.29MNT$ -69.42MNT$ -92.11MNT$ -118.38MNT$ -92.69M
NT$ -68.29MNT$ -69.42MNT$ -92.11MNT$ -118.38MNT$ -92.69M
Per Share Metrics
Basic EPSNT$ -1.15NT$ -1.27NT$ -1.83NT$ -2.40NT$ -1.88
Diluted EPSNT$ -1.15NT$ -1.27NT$ -1.83NT$ -2.40NT$ -1.88
Weighted Average Shares Outstanding59.38M54.66M50.39M49.32M49.18M
Weighted Average Shares Outstanding (Diluted)59.38M54.66M50.39M49.32M49.18M

Currency in TWD

Advagene Biopharma Co., Ltd. Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin